Clearance mechanism of a mannosylated antibody–enzyme fusion protein used in experimental cancer therapy

Author： Kogelberg Heide   Tolner Berend   Sharma Surinder K.   Lowdell Mark W   Qureshi Uzma   Robson Mathew   Hillyer Tim   Pedley R. Barbara   Vervecken Wouter   Contreras Roland   Begent Richard H.J.   Chester Kerry A.  

Publisher： Oxford University Press

ISSN： 1460-2423

Source： Glycobiology, Vol.17, Iss.1, 2007-01, pp. : 36-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycoforms obtained by expression in Pichia pastoris improve cancer targeting potential of a recombinant antibody-enzyme fusion protein

By Medzihradszky Katalin F.  

Glycobiology, Vol. 14, Iss. 1, 2004-01 ,pp. : 27-37

Oxford University Press

Access to resources Recommend Favorite

Antibody–cytokine fusion proteins: applications in cancer therapy

By Ortiz-Sánchez Elizabeth   Helguera Gustavo   Daniels Tracy R   Penichet Manuel L  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 5, 2008-05 ,pp. : 609-632

Informa Healthcare

Access to resources Recommend Favorite

Anthrax Fusion Protein Therapy of Cancer

By  

Current Protein and Peptide Science, Vol. 3, Iss. 4, 2002-08 ,pp. : 399-407

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody-directed enzyme prodrug therapy (ADEPT) for cancer

By Bagshawe Kenneth D   Sharma Surinder K   Begent Richard HJ  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1777-1789

Informa Healthcare

Access to resources Recommend Favorite

Anti-idiotype antibody vaccine therapy for cancer

By Bhattacharya-Chatterjee Malaya   Chatterjee Sunil K   Foon Kenneth A  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 869-881

Informa Healthcare

Access to resources Recommend Favorite